No Abstract BioWorld International CorrespondentPARIS - Domain Therapeutics SA, which was called Faust Pharmaceuticals SA until early December, has raised €2.1 million (US$2.8 million) to finance its drug discovery activities, which are focused on the identification of allosteric modulators of G Protein-Coupled Receptors (GPCRs).